Previous have studies stratified the tumour microenvironment (TME) based on tumour-infiltrating lymphocytes (TILs) and PD-L1 expression, in which the PD-L1+TILs+ TME is most likely to benefit from ICI therapy [12,13]. Here, CD274 is linked to neoplasm.